These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7237025)

  • 1. The effect of DDAVP on intravenous urography.
    Dixon AK; Webb JA; Cattell WR; Fry IK
    Br J Radiol; 1981 Jun; 54(642):484-7. PubMed ID: 7237025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antidiuretic action of 1-deamino-8-D-arginine vasopressin (DDAVP) in man.
    Radó JP; Marosi J; Szende L; Borbély L; Takó J; Fischer J
    Int J Clin Pharmacol Biopharm; 1976 Apr; 13(3):199-209. PubMed ID: 950263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidiuretic effect of perorally administered DDAVP in hydrated humans.
    Vilhardt H; Bie P
    Acta Endocrinol (Copenh); 1984 Apr; 105(4):474-6. PubMed ID: 6720233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of 1-deamino-8-D-arginine vasopressin after various routes of administration in healthy volunteers.
    Fjellestad-Paulsen A; Höglund P; Lundin S; Paulsen O
    Clin Endocrinol (Oxf); 1993 Feb; 38(2):177-82. PubMed ID: 8435898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasopressin influences renal function via a spinal action.
    Riphagen CL; Pittman QJ
    Brain Res; 1985 Jun; 336(2):346-9. PubMed ID: 4005591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidiuretic responses to injected desmopressin, alone and with indomethacin.
    Moses AM; Moses LK; Notman DD; Springer J
    J Clin Endocrinol Metab; 1981 May; 52(5):910-3. PubMed ID: 7228994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ddAVP does not stimulate acute changes in levels of medullary trimethylamines in humans.
    Avison MJ; Van Why SK; Siegel NJ
    J Am Soc Nephrol; 1993 Dec; 4(6):1379-84. PubMed ID: 8130365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-dependent stimulation of renal prostaglandin synthesis by deamino-8-D-arginine vasopressin in rats with hereditary diabetes insipidus.
    Walker LA; Frölich JC
    J Pharmacol Exp Ther; 1981 Apr; 217(1):87-91. PubMed ID: 7205662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experiences with intranasal and parenteral use of 1-desamino-8-D-arginine vasopressin (DDAVP). Use in a simple test of renal concentrating ability].
    Tuschy U; Szeszat S; Rindfleisch U
    Z Gesamte Inn Med; 1984 Jun; 39(11):265-8. PubMed ID: 6475171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impermeability of the blood-cerebrospinal fluid barrier to 1-deamino-8-D-arginine-vasopressin (DDAVP) in patients with acquired, communicating hydrocephalus.
    Sørensen PS; Vilhardt H; Gjerris F; Warberg J
    Eur J Clin Invest; 1984 Dec; 14(6):435-9. PubMed ID: 6441719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shortened duration of action of 1-deamino-8-D-arginine vasopressin (DDAVP) in patients with diabetes insipidus requiring high doses of peroral antidiuretic drugs.
    Radó JP; Marosi J; Fischer J
    J Clin Pharmacol; 1976 Oct; 16(10 Pt 1):518-24. PubMed ID: 789414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of vasopressin and its analogs on blood coagulation in rats].
    Golubeva MG; Kalishevskaia TM; Solov'eva ME
    Fiziol Zh (1978); 1990; 36(3):25-30. PubMed ID: 2394244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experiences with the intranasal and parenteral use of 1-desamino-8-D-arginine vasopressin (DDAVP)--effect of one time parenteral and intranasal applications].
    Tuschy U; Meinhold J; Szeszat S
    Z Gesamte Inn Med; 1983 Aug; 38(16):450-2. PubMed ID: 6636913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of arginine vasopressin suppression of ovine fetal lung fluid secretion: lack of V2-receptor effect.
    Albuquerque CA; Nijland MJ; Ross MG
    J Matern Fetal Med; 1998; 7(4):177-82. PubMed ID: 9730483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of lysine-vasopressin (LVP) and 1-deamino-8-D-arginine-vasopressin (dDAVP) upon electrical potential, short-circuit current and transepithelial D.C. resistance of the frog skin.
    Bakos P; Ponec J; Lichardus B
    Gen Physiol Biophys; 1984 Aug; 3(4):297-305. PubMed ID: 6094299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between the dose of 1-deamino-8-d-arginine vasopressin (ddavp) and the antidiuretic response in man.
    Radó JP; Marosi J; Fischer J; Takó J; Kiss N
    Endokrinologie; 1975 Nov; 66(2):184-95. PubMed ID: 1236681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of acute hemodynamic effects of antidiuretic agonists in conscious dogs.
    Liard JF
    J Cardiovasc Pharmacol; 1988 Feb; 11(2):174-80. PubMed ID: 2452311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxytocin and [1-deamino, 8-D-arginine]-vasopressin (dDAVP): intrathecal effects on blood pressure, heart rate and urine output.
    Riphagen CL; Pittman QJ
    Brain Res; 1986 May; 374(2):371-4. PubMed ID: 3755073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Augmentation by chlorpropamide of 1-deamino-8-D-arginine vasopressin-induced antidiuresis and stimulation of renal medullary adenylate cyclase and accumulation of adenosine 3',5'-monophosphate.
    Moses AM; Coulson R
    Endocrinology; 1980 Mar; 106(3):967-72. PubMed ID: 6243558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidiuretic effect and pharmacokinetics of oral 1-desamino-8-D-arginine vasopressin. 1. Studies in adults and children.
    Williams TD; Dunger DB; Lyon CC; Lewis RJ; Taylor F; Lightman SL
    J Clin Endocrinol Metab; 1986 Jul; 63(1):129-32. PubMed ID: 3711257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.